rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2003-9-10
|
pubmed:abstractText |
Cannabinoid use could potentially alter HIV RNA levels by two mechanisms: immune modulation or cannabinoid-protease inhibitor interactions (because both share cytochrome P-450 metabolic pathways).
|
pubmed:grant |
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1539-3704
|
pubmed:author |
pubmed-author:AbergJudith AJA,
pubmed-author:AbramsDonald IDI,
pubmed-author:AweekaFrancesca TFT,
pubmed-author:BacchettiPeterP,
pubmed-author:BenowitzNeal LNL,
pubmed-author:BredtBarry MBM,
pubmed-author:DeeksSteven GSG,
pubmed-author:ElbeikTarek ATA,
pubmed-author:HiltonJoan FJF,
pubmed-author:KoselBradleyB,
pubmed-author:LeiserRoslyn JRJ,
pubmed-author:McCuneJoseph MJM,
pubmed-author:MitchellThomas FTF,
pubmed-author:MulliganKathleenK,
pubmed-author:SchambelanMorrisM,
pubmed-author:ShadeStarley BSB
|
pubmed:issnType |
Electronic
|
pubmed:day |
19
|
pubmed:volume |
139
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
258-66
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:12965981-Administration, Oral,
pubmed-meshheading:12965981-CD4 Lymphocyte Count,
pubmed-meshheading:12965981-CD4-Positive T-Lymphocytes,
pubmed-meshheading:12965981-CD8-Positive T-Lymphocytes,
pubmed-meshheading:12965981-Cannabinoids,
pubmed-meshheading:12965981-Drug Interactions,
pubmed-meshheading:12965981-Female,
pubmed-meshheading:12965981-HIV Infections,
pubmed-meshheading:12965981-HIV Protease Inhibitors,
pubmed-meshheading:12965981-HIV-1,
pubmed-meshheading:12965981-Humans,
pubmed-meshheading:12965981-Indinavir,
pubmed-meshheading:12965981-Male,
pubmed-meshheading:12965981-Nelfinavir,
pubmed-meshheading:12965981-RNA, Viral,
pubmed-meshheading:12965981-Tetrahydrocannabinol,
pubmed-meshheading:12965981-Viral Load
|
pubmed:year |
2003
|
pubmed:articleTitle |
Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trial.
|
pubmed:affiliation |
University of California, San Francisco, and Gladstone Institute of Virology and Immunology, San Francisco, California 94110, USA.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Randomized Controlled Trial
|